PTH and hypophosphatemia: Re-evaluation at 16 weeks revealed hypercalcemia, worsening of the hypophosphatemia, persistence of the elevated parathyroid hormone (PTH) along with normalization of serum 25-hydroxy-vitamin-D [25(OH)D] (Table 1).